Table 4.
Grouping of second-line anti-TB drugs for treatment of multidrug-resistant TB
| Group | Drugs |
|---|---|
| Group 1: First-line oral drugs |
Pyrazinamide |
| Ethambutol | |
| Rifabutin | |
| Group 2: Injectable drugs |
Kanamycin |
| Amikacin | |
| Capreomycin | |
| Streptomycin | |
| Group 3: Fluoroquinolones |
Levofloxacin |
| Moxifloxacin | |
| Ofloxacin | |
| Group 4: Oral bacteriostatic second-line drugs |
Para-aminosalicylic acid |
| Cycloserine | |
| Terizidone | |
| Ethionamide | |
| Protionamide | |
| Group 5: Drugs with an unclear role in the treatment of drug-resistant TB |
Clofazimine |
| Linezolid | |
| Amoxicillin/clavulanate | |
| Thioacetazone | |
| Imipenem/cilastatin | |
| High-dose isoniazid | |
| Clarithromycin |